Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

210 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Detection of dysplastic lesions by fluorescence in a model of chronic colitis in rats after local application of 5-aminolevulinic acid and its esterified derivatives.
Endlicher E, Rümmele P, Hausmann F, Rath HC, Knüchel R, Krieg RC, Schölmerich J, Messmann H. Endlicher E, et al. Among authors: Messmann H. Photochem Photobiol. 2004 Feb;79(2):189-92. doi: 10.1562/0031-8655(2004)079<0189:dodlbf>2.0.co;2. Photochem Photobiol. 2004. PMID: 15068031
ALA-methylester (m-ALA), ALA-hexylester (h-ALA) and ALA-benzylester (b-ALA) were used at a concentration of 0.003, 0.002 and 0.002 mol/L, respectively. ...On using h-ALA, sensitivity was 60% (3/5) with a specificity of 51%. Using m-ALA and b-ALA, sensitivity values were 25% and 33%, and values for specificity were 62% and 63%, respectively. ...
ALA-methylester (m-ALA), ALA-hexylester (h-ALA) and ALA-benzylester (b-ALA) were used at a concentration of 0.003, 0.002 and 0.002 mo …
Anthocyanins Prevent Colorectal Cancer Development in a Mouse Model.
Lippert E, Ruemmele P, Obermeier F, Goelder S, Kunst C, Rogler G, Dunger N, Messmann H, Hartmann A, Endlicher E. Lippert E, et al. Among authors: Messmann H. Digestion. 2017;95(4):275-280. doi: 10.1159/000475524. Epub 2017 May 12. Digestion. 2017. PMID: 28494451
Comparison of inpatient and outpatient upper gastrointestinal haemorrhage.
Klebl FH, Bregenzer N, Schöfer L, Tamme W, Langgartner J, Schölmerich J, Messmann H. Klebl FH, et al. Among authors: Messmann H. Int J Colorectal Dis. 2005 Jul;20(4):368-75. doi: 10.1007/s00384-004-0642-0. Epub 2004 Nov 13. Int J Colorectal Dis. 2005. PMID: 15551100
Bile salt-induced apoptosis in human colon cancer cell lines involves the mitochondrial transmembrane potential but not the CD95 (Fas/Apo-1) receptor.
Wachs FP, Krieg RC, Rodrigues CM, Messmann H, Kullmann F, Knüchel-Clarke R, Schölmerich J, Rogler G, Schlottmann K. Wachs FP, et al. Among authors: Messmann H. Int J Colorectal Dis. 2005 Mar;20(2):103-13. doi: 10.1007/s00384-004-0616-2. Epub 2004 Sep 7. Int J Colorectal Dis. 2005. PMID: 15365741
Risk factors for mortality in severe upper gastrointestinal bleeding.
Klebl F, Bregenzer N, Schöfer L, Tamme W, Langgartner J, Schölmerich J, Messmann H. Klebl F, et al. Among authors: Messmann H. Int J Colorectal Dis. 2005 Jan;20(1):49-56. doi: 10.1007/s00384-004-0624-2. Epub 2004 Aug 19. Int J Colorectal Dis. 2005. PMID: 15322836
Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study.
Kullmann F, Hollerbach S, Dollinger MM, Harder J, Fuchs M, Messmann H, Trojan J, Gäbele E, Hinke A, Hollerbach C, Endlicher E. Kullmann F, et al. Among authors: Messmann H. Br J Cancer. 2009 Apr 7;100(7):1032-6. doi: 10.1038/sj.bjc.6604983. Epub 2009 Mar 17. Br J Cancer. 2009. PMID: 19293797 Free PMC article. Clinical Trial.
Patients received cetuximab 400 mg m(-2) at first infusion followed by weekly 250 mg m(-2) combined with gemcitabine 1000 mg m(-2) as a 100 min infusion on day 1 and oxaliplatin 100 mg m(-2) as a 2-h infusion on day 2 every 2 weeks. ...
Patients received cetuximab 400 mg m(-2) at first infusion followed by weekly 250 mg m(-2) combined with gemcitabine 1000 mg m(-2) as a 100 …
[Fluorescence endoscopy in gastroenterology].
Messmann H. Messmann H. Z Gastroenterol. 2000 Jan;38(1):21-30. doi: 10.1055/s-2000-14846. Z Gastroenterol. 2000. PMID: 10689744 Review. German.
[Photodynamic diagnosis of gastrointestinal precancerous lesions after sensitization with 5-aminolevulinic acid. A pilot study].
Messmann H, Knüchel R, Endlicher E, Hauser T, Szeimies RM, Kullmann F, Bäumler W, Schölmerich J. Messmann H, et al. Dtsch Med Wochenschr. 1998 Apr 24;123(17):515-21. doi: 10.1055/s-2007-1024003. Dtsch Med Wochenschr. 1998. PMID: 9601473 German.
Photodynamic diagnosis (PDD) took place 4-8 h after oral and ca. 1-2 h after local sensitization with blue light (D-light, Storz, Tuttlingen, Germany). ...
Photodynamic diagnosis (PDD) took place 4-8 h after oral and ca. 1-2 h after local sensitization with blue light (D-light, Sto …
210 results
Jump to page
Feedback